World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12616000299404
Date of registration: 07/03/2016
Prospective Registration: Yes
Primary sponsor: Dr. Long Chiau Ming
Public title: The Effect of Facial Candling on Inflammatory Mediators and Pain in Allergic Rhinitis Patients:A randomized controlled trial
Scientific title: The Effect of Facial Candling on Inflammatory Mediators and Pain in Allergic Rhinitis Patients:A randomized controlled trial
Date of first enrolment: 01/04/2016
Target sample size: 66
Recruitment status: Not yet recruiting
URL:  https://anzctr.org.au/ACTRN12616000299404.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
Malaysia
Contacts
Name: Miss Nor Faizatul Fatikah Binti Ismail   
Address:  Brain research labroratory, level 7, Universiti Teknologi MARA (UiTM), Campus Puncak Alam, 42300 Puncak Alam, Selangor, Malaysia Malaysia
Telephone: +6016-8751792
Email: fzbiotech12@gmail.com
Affiliation: 
Name: Dr Long Chiau Ming   
Address:  Faculty of Pharmacy Level 11, FF 1 , Universiti Teknologi MARA (UiTM), Campus Puncak Alam, 42300 Puncak Alam, Selangor, Malaysia. Malaysia
Telephone: +6012-4778468
Email: longchiauming@gmail.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1.Age between 18- 65 years old
2.Participant had a positive skin prick test to at least one of :
-seafood; or
-house dust mite; or
-animal dander; or
-pollen
3.Pass urine pregnancy test for female.
4.Willing to participate in this study

Exclusion criteria: 1.Pregnant woman
2.Asthma and Chronic obstructive pulmonary disease (COPD) patients
3.Patients who taking pain killer pills, received antihistamine drug and steroid


Age minimum: 18 Years
Age maximum: 65 Years
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation
Allergic rhinitis;
Allergic rhinitis
Inflammatory and Immune System - Allergies
Alternative and Complementary Medicine - Other alternative and complementary medicine
Intervention(s)
The patients Allergic rhinitis in group (Group A) will be treated by one certified practitioner of traditional facial candling, with the treatment being applied within 15 minutes in one session. The practitioner will pass the smoke release from facial candle around the patients face. The white like powder appears on the patients face will be clean with water.
Primary Outcome(s)
The level of substance P in nasal mucus and blood samples[The nasal mucus and blood samples will be taken 5 minutes before the treatment (pre-treatment), and immediately after treatment (post-treatment).]
Secondary Outcome(s)
The level of inflammatory mediators [i.e. TNF-alpha, IL-4, IL-5, IL-6,IL-10 and IL-13, in both blood and nasal mucus samples.[The nasal mucus and blood samples will be taken 5 minutes before the treatment (pre- treatment) and immediately after the treatment (post-treatment).]
Secondary ID(s)
NIL
Source(s) of Monetary Support
Research Acculturation Grant Scheme (RAGS), Universiti Teknologi MARA (UiTM
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Research Ethics Committe UiTM
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history